If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
554.00    3.00 (0.54%)
Bid:
553.00
Ask:
554.00
Spread: 1.00 (0.181%)
Market Cap: £547.06m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Share Exchange Ratio & Listing Application Details

2 Jan 2020 07:00

RNS Number : 4676Y
Galliford Try PLC
02 January 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

2 January 2020

 

For immediate release

 

Galliford Try plc

Share Exchange Ratio Announcement

Final number of New Galliford Try Shares to be admitted and listed

 

Following completion of the proposed disposal of the Linden Homes and Partnerships & Regeneration divisions of Galliford Try plc ("Galliford Try") (the "Transaction"), the Board of Galliford Try announces that based on 111,053,489 Galliford Try Shares in issue as at the Scheme Record Time, Galliford Try Shareholders will receive approximately 0.5739521 new Bovis Homes Shares for each Galliford Try Share held at the Scheme Record Time.

The Board of Galliford Try also announces that further to the application by Galliford Try Holdings plc ("New Galliford Try") to the FCA for the ordinary shares of New Galliford Try (the "New Galliford Try Shares") to be admitted to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the London Stock Exchange on 3 January 2020, the total issued ordinary share capital of New Galliford Try for which applications have been made is 111,053,489 fully paid ordinary shares with a nominal value of 50 pence each.

General

Capitalised terms in this announcement, unless otherwise defined, have the same meanings as set out in the circular published by Galliford Try on 8 November 2019 in relation to the Transaction.

All references in this announcement to times are to times in London.

 

Enquiries:

Galliford Try plc

Graham Prothero, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel and Company Secretary

 

01895 855 001

 

Rothschild & Co (Lead Financial Adviser to Galliford Try and New Galliford Try)

John Deans

Neil Thwaites

Peter Everest

 

020 7280 5000

HSBC Bank plc (Joint Financial Adviser, Joint Sponsor and Joint Corporate Broker to Galliford Try and New Galliford Try)

Mark Dickenson

Adam Miller

Keith Welch

Diraj Ramchandani

 

020 7991 8888

Peel Hunt LLP (Joint Financial Adviser, Joint Sponsor and Joint Corporate Broker to Galliford Try and New Galliford Try)

Charles Batten

Edward Knight

Harry Nicholas

 

020 7418 8900

Tulchan Communications (PR Adviser to Galliford Try)

James Macey White

Martin Pengelley

Elizabeth Snow

 

020 7353 4200

 

Important Notice

This announcement is for information purposes only and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement shall constitute an offer or invitation to underwrite, buy, subscribe, sell or issue or the solicitation of an offer to buy, sell, acquire, dispose or subscribe for shares or any other securities.

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as lead financial adviser to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and Admission and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of Rothschild & Co or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

HSBC Bank plc ("HSBC"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting as joint financial adviser, joint sponsor and joint corporate broker to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and Admission and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of HSBC or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Peel Hunt LLP ("Peel Hunt"), which is regulated by the Financial Conduct Authority in the United Kingdom, is acting as joint financial adviser, joint sponsor and joint corporate broker to Galliford Try and New Galliford Try in connection with the proposed sale of the Disposal Group (excluding for the avoidance of doubt the associated restructuring) and Admission and for no one else in connection with the Transaction and will not be responsible to anyone other than Galliford Try or New Galliford Try for providing the protections afforded to clients of Peel Hunt or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

This announcement has been issued by Galliford Try and is the sole responsibility of Galliford Try. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Rothschild & Co, HSBC or Peel Hunt, or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to any interested party or its advisers, and any responsibility or liability, whether arising in tort, contract or otherwise in respect of this announcement or any such statement, therefore is expressly disclaimed.

Notice to US Shareholders

The issue of the shares in New Topco relates to shares of a Jersey company and is proposed to be effected by means of a scheme of arrangement under the laws of England and Wales. A transaction effected by means of a scheme of arrangement is not subject to proxy solicitation or tender offer rules under the US Securities Exchange Act of 1934, as amended. Accordingly, the scheme of arrangement is subject to the disclosure requirements, rules and practices applicable in the United Kingdom to schemes of arrangement, which differ from the requirements of US proxy solicitation or tender offer rules.

Neither the shares in New Topco, nor the Consideration Shares proposed to be issued by Bovis Homes, have been, and nor will they be, registered under the US Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of any state or other jurisdiction of the United States. Accordingly, neither the shares in New Topco nor the Consideration Shares may be offered, sold, resold, delivered, distributed or otherwise transferred, directly or indirectly, in or into the United States absent registration under the Securities Act or an exemption therefrom. The shares in New Topco and the Consideration Shares are expected to be issued in reliance upon the exemption from the registration requirements of the Securities Act provided by Section 3(a)(10) thereof. Galliford Try Shareholders who will be affiliates of New Topco after the Scheme becomes Effective or affiliates of Bovis Homes after completion of the Transaction will be subject to certain US transfer restrictions relating to the shares in New Topco and the Consideration Shares received in connection with the Transaction.

The New Galliford Try Shares have not been and are not required to be registered under the Securities Act. The New Galliford Try Shares should not be treated as "restricted securities" within the meaning of Rule 144(a)(3) under the Securities Act and persons who receive New Galliford Try Shares (other than affiliates) may resell them without restriction under the Securities Act.

For the purposes of qualifying for the exemption from the registration requirements of the Securities Act afforded by Section 3(a)(10), Galliford Try has advised the Court through counsel that its sanctioning of the Scheme will be relied upon by New Topco and Bovis Homes as an approval of the Scheme following a hearing on its fairness to Galliford Try Shareholders.

It may be difficult for US Shareholders to enforce their rights and claims arising out of the US federal securities laws, since New Galliford Try, Bovis Homes and Galliford Try are located in countries other than the United States, and some or all of their officers and directors may be residents of countries other than the United States. US Shareholders may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgment.

None of the securities referred to in this announcement have been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any other US regulatory authority, nor have such authorities passed upon or determined the adequacy or accuracy of the information contained in this announcement. Any representation to the contrary is a criminal offence in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISDZGGMLMGGGZM
Date   Source Headline
1st Jul 202610:00 amRNSTotal Voting Rights
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.